• Explore /
  • Poster
  • / Phase II study of sintilimab combined with FLOT regimen for neoadjuvant treatment of gastric or gastroesophageal junction (GEJ) adenocarcinoma.

Phase II study of sintilimab combined with FLOT regimen for neoadjuvant treatment of gastric or gastroesophageal junction (GEJ) adenocarcinoma.

Abstract Poster

Authors

null

Ning Li

Department of Medical Oncology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China

Ning Li , Zhi Li , Qiang Fu , Bin Zhang , Jian Zhang , XiangBin Wan , Chaomin Lu , Jinbang Wang , Wenying Deng , Chen Wei , Yijie Ma , Liangyu Bie , Mengyu Wang , Suxia Luo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Esophageal and Gastric Cancer

Track

Esophageal and Gastric Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04341857

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 216)

DOI

10.1200/JCO.2021.39.3_suppl.216

Abstract #

216

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Hongli Li

First Author: MARIA ALSINA

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.

Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.

First Author: Yuri Yoshinami

First Author: Mark R. Middleton